Results 31 to 40 of about 5,235,363 (361)

Comprehensive Molecular Characterization of Human Colon and Rectal Cancer

open access: yesNature, 2012
To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of 276 samples, analysing exome sequence, DNA copy number, promoter methylation and messenger RNA and microRNA expression.
D. Muzny   +312 more
semanticscholar   +1 more source

Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer - Preliminary results [PDF]

open access: yes, 2003
Background: The local recurrence rate of colorectal cancer has been significantly reduced due to the use of combined radiochemotherapy. Despite this improvement regarding locally advanced tumour recurrences, the treatment strategy for pre-treated ...
Schaffer, P.M.   +21 more
core   +1 more source

Rectal stenosis due to solitary pelvic recurrence of hilar cholangiocarcinoma

open access: yesJGH Open, 2020
An 85‐year‐old woman was admitted to a hospital with abdominal pain. Five years prior to admission, she had a history of hilar cholangiocarcinoma of pStage IIIC. Contrast‐enhanced computed tomography showed a mass between the rectum and uterus as well as
Ikuma Shioi   +6 more
doaj   +1 more source

Diagnostic value of computed tomography (CT) and positron emission tomography (PET) for paraaortic lymph node metastasis from left-sided colon and rectal cancer

open access: yesAsian Journal of Surgery, 2020
Summary: Background/objective: Paraaortic lymph node (PALN) metastasis influences treatment strategy for colorectal cancer. The aims of this study were to elucidate the diagnostic value of computed tomography (CT) and positron emission tomography (PET ...
Nozomu Nakai   +10 more
doaj   +1 more source

Comprehensive Analysis of miRNA-Mediated Regulatory Network and Identification of Prognosis Biomarkers in Rectal Cancer

open access: yesFrontiers in Genetics, 2022
Rectal cancer is a malignant tumor with poor prognosis. Identification of prognostic biomarkers is needed to improve overall survival of rectal cancer patients. Here, we firstly identified miR-20a-5p significantly classifying high-risk group and low-risk
Tingting Tang   +6 more
doaj   +1 more source

Developing Nurses’ Performance Guidelines for Patients with Rectal Cancer Undergoing Radiotherapy [PDF]

open access: yesEgyptian Journal of Health Care, 2022
Background: Rectal cancer is one of the most common forms of cancer and one of the top cancer killers. One of the modalities treatment is radiotherapy that causes fewer side effects as fatigue, skin reactions, gastrointestinal disturbance, rectal ...
Zeinab Hussein Baker   +3 more
doaj   +1 more source

NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.

open access: yesThe Journal of the National Comprehensive Cancer Network, 2020
The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the ...
A. Benson   +35 more
semanticscholar   +1 more source

Development and validation of MRI‐based deep learning models for prediction of microsatellite instability in rectal cancer

open access: yesCancer Medicine, 2021
Microsatellite instability (MSI) predetermines responses to adjuvant 5‐fluorouracil and immunotherapy in rectal cancer and serves as a prognostic biomarker for clinical outcomes.
Wei Zhang   +9 more
semanticscholar   +1 more source

Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity [PDF]

open access: yes, 2002
Background: The standard therapy for patients with clinically resectable rectal cancer is generally considered to be surgery, If the patient is diagnosed with advanced disease, postoperative radiochemotherapy (RCT) is usually recommended. In our study we
Wilkowski, R.   +4 more
core   +1 more source

M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer

open access: yesFrontiers in Oncology, 2021
Rectal cancer (RC) is the leading cause of tumor-related death among both men and women. The efficacy of immunotherapy for rectal cancer is closely related to the immune infiltration level.
Changjing Cai   +25 more
doaj   +1 more source

Home - About - Disclaimer - Privacy